Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Abramson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical and Experimental Neuropsychology|March 11, 2011
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological changeLucette A Cysique, Donald Franklin, Ian Abramson, et al.
Journal of Neuroimmunology|March 25, 2023
CD3<sup>+</sup>CD56<sup>+</sup> and CD3<sup>-</sup>CD56<sup>+</sup> lymphocytes in the cerebrospinal fluid of persons with HIV-1 subtypes B and CSergio M de Almeida, Miriam Perlingeiro Beltrame, Bin Tang, et al.
Journal of Affective Disorders|November 30, 2007
Two-year prospective study of major depressive disorder in HIV-infected menJ Hampton Atkinson, Robert K Heaton, Thomas L Patterson, et al.
Neurology|May 13, 2014
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic declineIgor Grant, Donald R Franklin, Reena Deutsch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER studyRobert K Heaton, Donald R Franklin, Reena Deutsch, et al.
Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.
Journal of Neurovirology|February 20, 2014
HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matterJohn R Keltner, Christine Fennema-Notestine, Florin Vaida, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical and Experimental Neuropsychology|March 11, 2011
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological changeLucette A Cysique, Donald Franklin, Ian Abramson, et al.
Journal of Neuroimmunology|March 25, 2023
CD3<sup>+</sup>CD56<sup>+</sup> and CD3<sup>-</sup>CD56<sup>+</sup> lymphocytes in the cerebrospinal fluid of persons with HIV-1 subtypes B and CSergio M de Almeida, Miriam Perlingeiro Beltrame, Bin Tang, et al.
Journal of Affective Disorders|November 30, 2007
Two-year prospective study of major depressive disorder in HIV-infected menJ Hampton Atkinson, Robert K Heaton, Thomas L Patterson, et al.
Neurology|May 13, 2014
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic declineIgor Grant, Donald R Franklin, Reena Deutsch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER studyRobert K Heaton, Donald R Franklin, Reena Deutsch, et al.
Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.
Journal of Neurovirology|February 20, 2014
HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matterJohn R Keltner, Christine Fennema-Notestine, Florin Vaida, et al.
Pageof 2